BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2112618)

  • 1. Response of tumor and host to hyperalimentation and antiglutamine treatments.
    Chance WT; Cao LQ; Fischer JE
    JPEN J Parenter Enteral Nutr; 1990; 14(2):122-8. PubMed ID: 2112618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acivicin reduces tumor growth during total parenteral nutrition (TPN).
    Chance WT; Cao L; Nelson JL; Foley-Nelson T; Fischer JE
    Surgery; 1987 Aug; 102(2):386-94. PubMed ID: 3112985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin and acivicin improve host nutrition and prevent tumor growth during total parenteral nutrition.
    Chance WT; Cao L; Fischer JE
    Ann Surg; 1988 Oct; 208(4):524-31. PubMed ID: 3140745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolonged survival by tumor-bearing rats treated with acivicin and total parenteral nutrition.
    Chance WT; Cao LQ; Fischer JE
    J Natl Cancer Inst; 1990 Mar; 82(5):432-4. PubMed ID: 2106035
    [No Abstract]   [Full Text] [Related]  

  • 5. Clenbuterol plus acivicin decrease tumor growth and increase muscle mass in rats maintained on total parenteral nutrition.
    Chance WT; Cao L; Zhang FS; Fischer JE
    Am J Surg; 1991 Jan; 161(1):51-6. PubMed ID: 1899011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parenteral vs enteral nutrition in tumor-bearing rats.
    Stallion A; Foley-Nelson T; Chance WT; Zhang FS; Fischer JE
    JPEN J Parenter Enteral Nutr; 1994; 18(2):148-53. PubMed ID: 8201750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of tumor and parenteral nutrition on jejunal mucosal polyamines.
    Chance WT; Noguchi Y; Zhang X; Hasselgren PO; Fischer JE
    Nutr Cancer; 1995; 23(1):23-32. PubMed ID: 7739912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of tumor growth following treatment with a glutamine antimetabolite.
    Chance WT; Cao L; Kim MW; Nelson JL; Fischer JE
    Life Sci; 1988; 42(1):87-94. PubMed ID: 3336272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clenbuterol treatment increases muscle mass and protein content of tumor-bearing rats maintained on total parenteral nutrition.
    Chance WT; Cao LQ; Zhang FS; Foley-Nelson T; Fischer JE
    JPEN J Parenter Enteral Nutr; 1991; 15(5):530-5. PubMed ID: 1942465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor and host carcass changes during total parenteral nutrition in an anorectic rat-tumor system.
    Popp MB; Kirkemo AK; Morrison SD; Brennan MF
    Ann Surg; 1984 Feb; 199(2):205-10. PubMed ID: 6421254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunostimulation following fish oil-based parenteral nutrition in tumor-bearing rats.
    Chance WT; Ogle CK; Thomas I; Zhou L; Zhang X; Basanta M; Fischer JE
    Nutr Cancer; 1996; 26(3):303-12. PubMed ID: 8910912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acivicin: a new glutamine antagonist in clinical trials.
    O'Dwyer PJ; Alonso MT; Leyland-Jones B
    J Clin Oncol; 1984 Sep; 2(9):1064-71. PubMed ID: 6470756
    [No Abstract]   [Full Text] [Related]  

  • 13. Multi-enzyme-targeted chemotherapy by acivicin and actinomycin.
    Weber G; Prajda N; Lui MS; Denton JE; Aoki T; Sebolt J; Zhen YS; Burt ME; Faderan MA; Reardon MA
    Adv Enzyme Regul; 1982; 20():75-96. PubMed ID: 6180609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resting and activity energy expenditure during total parenteral nutrition in rats with methylcholanthrene-induced sarcoma.
    Popp MB; Brennan MF; Morrison SD
    Cancer; 1982 Mar; 49(6):1212-20. PubMed ID: 6800630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substituting ornithine for arginine in total parenteral nutrition eliminates enhanced tumor growth.
    Grossie VB; Nishioka K; Ajani JA; Ota DM
    J Surg Oncol; 1992 Jul; 50(3):161-7. PubMed ID: 1619938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of acivicin and dipyridamole on hepatoma 3924A cells.
    Zhen YS; Lui MS; Weber G
    Cancer Res; 1983 Apr; 43(4):1616-9. PubMed ID: 6831407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of resistance of a variant of P388 leukemia to L-(alpha S,5S)-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (acivicin).
    Jayaram HN; Ardalan B; Deas M; Johnson RK
    Cancer Res; 1985 Jan; 45(1):207-12. PubMed ID: 2578092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Total parenteral nutrition in a methylcholanthrene-induced rat sarcoma model.
    Popp MB; Morrison SD; Brennan MF
    Cancer Treat Rep; 1981; 65 Suppl 5():137-43. PubMed ID: 6809323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of glutamine-enriched total parenteral nutrition on tumor growth and host tissues.
    Austgen TR; Dudrick PS; Sitren H; Bland KI; Copeland E; Souba WW
    Ann Surg; 1992 Feb; 215(2):107-13. PubMed ID: 1546896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of parenteral nutrition on tumor growth and erythrocyte polyamine levels in the rat.
    Grossie VB; Nishioka K; Chang TH; Patenia D; Benitez MM; Ajani JA; Ota DM
    JPEN J Parenter Enteral Nutr; 1989; 13(6):590-5. PubMed ID: 2515305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.